Web Images Videos Maps News Shopping Gmail more »
Sign in
Scholar Home  
  Advanced Scholar Search
Scholar Preferences
Scholar Results 1 - 10 of about 73 citing WADE: Neurologic symptoms associated with parenteral acyclovir treatment after marrow transplanta.... (0.10 sec) 

Acyclovir-induced renal failure* 1:: Clinical course and histology


MH Sawyer, DE Webb, JE Balow, SE Straus - The American journal of medicine, 1988 - Elsevier
Four patients with a chronic fatigue syndrome experienced five episodes of acute renal insufficiency
associated with high-dose (500 mg/m 2 ) intravenous acyclovir administered intravenously as
one-hour infusions. Nephrotoxicity developed despite precautions to avoid volume ...
Cited by 99 - Related articles - All 5 versions

Guidelines for the prevention and treatment of B-virus infections in exposed …


GP Holmes, LE Chapman, JA Stewart, SE Straus, … - Clinical Infectious …, 1995 - jstor.org
Page 1. 421 Guidelines for the Prevention and Treatment of B-Virus Infections in Exposed
Persons Gary P. Holmes,* Louisa E. Chapman, John A. Stewart, Stephen E. Straus, Julia
K. Hilliard, David S. Davenport, and the B Virus Working Groupt ...
Cited by 77 - Related articles - BL Direct - All 3 versions

Current pharmacological approaches to the therapy of varicella zoster virus …

- kuleuven.be [PDF] 
R Snoeck, G Andrei, ED Clercq - Drugs, 1999 - ingentaconnect.com
Abstract . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 187 1. Clinical Presentation
of Varicella Zoster Virus (VZV) Disease . . . . . . . . . . . . . . . . . . . . . . 188 2. Prevention of VZV Infections
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 190 2.1 Passive Immunisation . . . . . . . . . . . . . ...
Cited by 67 - Related articles - BL Direct - All 4 versions

Antiviral therapy: current concepts and practices.

- nih.gov
B Bean - Clinical Microbiology Reviews, 1992 - Am Soc Microbiol
Page 1. CLINICAL MICROBIOLOGY REVIEWS, Apr. 1992, p. 146-182 Vol. 5, No.
2 0893-8512/92/020146-37$02.00/0 Copyright © 1992, American Society for
Microbiology Antiviral Therapy: Current Concepts and Practices ...
Cited by 63 - Related articles - All 6 versions

[CITATION] Antiviral agents


FG HAYDEN, RG DOUGLAS JR - Anti-Infective Therapy, 1985 - Churchill Livingstone
Cited by 55 - Related articles - All 2 versions

Herpes simplex virus type 2 meningoencephalitis resistant to acyclovir in a patient …


A Gateley, RM Gander, PC Johnson, S Kit, H … - The Journal of infectious …, 1990 - jstor.org
Herpes Simplex Virus Type 2 Meningoencephalitis Resistant to Acyclovir in a ... Ann
Gateley, Rita M. Gander,* Philip C. Johnson, Saul Kit, Haruki Otsuka, and Steve Kohlt From the
Division of General Internal Medicine, the Departments of Pathology and Pediatrics, and ...
Cited by 50 - Related articles - All 3 versions

Herpes simplex virus infection in the immunocompromised cancer patient

- ascopubs.org [PDF] 
CI Bustamante, JC Wade - Journal of Clinical Oncology, 1991 - jco.ascopubs.org
From the Section of Infectious Diseases and Microbiology, University of Maryland Cancer
Center, Baltimore; and Divi- sions of Infectious Diseases and Oncology, Department of
Medicine, University of Maryland School of Medicine, Balti- more, MD. Submitted January ...
Cited by 47 - Related articles - All 6 versions

Interactions and toxicities of drugs used in patients with AIDS


BL Lee, S Safrin - Clinical Infectious Diseases, 1992 - jstor.org
Interactions and Toxicities of Drugs Used in Patients with AIDS ... From the Department of Medicine
and the Divisions of Pharmacology and Infectious Diseases and of Epidemiology and
Biostatistics, University of California, San Francisco; and the San Francisco General ...
Cited by 46 - Related articles - All 3 versions

Acyclovir-induced neurotoxicity: concentration-side effect relationship in acyclovir …


WE Haefeli, RAZ Schoenenberger, P Weiss, RF … - The American journal of …, 1993 - Elsevier
: We measured the highest acyclovir serum levels reported so far (229.9 μmol/L = 51.8
mg/L). Impairment of consciousness developed with a remarkable temporal delay of 24 to 48
hours after occurrence of peak serum concentrations and resolved with a comparable ...
Cited by 41 - Related articles - All 4 versions

Treatment of cytomegaloviral pneumonia with high-dose acyclovir and human …


JC Wade, RW McGuffin, SC Springmeyer, B … - The Journal of infectious …, 1983 - jstor.org
THE JOURNAL OF INFECTIOUS DISEASES * VOL. 148, NO. 3 * SEPTEMBER 1983 @ 1983
by The University of Chicago. All rights reserved. 0022-1899/83/4803-0024$00.75 ... Treatment
of Cytomegaloviral Pneumonia with High-Dose Acyclovir and Human
Cited by 43 - Related articles - All 4 versions


Result Page: 

1

2

3

4

5

6

7

8

Next


 


Go to Google Home - About Google - About Google Scholar

©2009 Google